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Naive mouse embryonic stem cells (mESCs) and
primed epiblast stem cells (mEpiSCs) represent suc-
cessive snapshots of pluripotency during embryo-
genesis. Using transcriptomic and epigenomic
mapping we show that a small fraction of transcripts
are differentially expressed between mESCs and
mEpiSCs and that these genes show expected
changes in chromatin at their promoters and en-
hancers. Unexpectedly, the cis-regulatory circuitry
of genes that are expressed at identical levels be-
tween these cell states also differs dramatically. In
mESCs, these genes are associated with dominant
proximal enhancers and dormant distal enhancers,
which we term seed enhancers. In mEpiSCs, the
naive-dominant enhancers are lost, and the seed en-
hancers take up primary transcriptional control. Seed
enhancers have increased sequence conservation
and show preferential usage in downstream somatic
tissues, often expanding into super enhancers.
We propose that seed enhancers ensure proper
enhancer utilization and transcriptional fidelity as
mammalian cells transition from naive pluripotency
to a somatic regulatory program.
INTRODUCTION
At themolecular level, pluripotency is under the control of a com-
plex array of regulatory mechanisms that maintain chromatin in a
state permissive to differentiation into each of the early somatic
and germ cell lineages. Recent evidence shows that pluripo-
tency is not a single entity and can be maintained in either a
‘‘naive’’ or ‘‘primed’’ state (Brons et al., 2007; Chenoweth
et al., 2010; Nichols and Smith, 2009; Tesar et al., 2007). Naive
pluripotent cells, typified by mouse embryonic stem cells854 Cell Stem Cell 14, 854–863, June 5, 2014 ª2014 Elsevier Inc.(mESCs), represent the preimplantation inner cell mass and
are widely utilized for developmental genetics because they
are capable of extensive contribution to chimeric animals upon
reintroduction back into the blastocyst (Bradley et al., 1984;
Evans and Kaufman, 1981; Martin, 1981). On the other hand,
primed pluripotent cells, typified by mouse epiblast stem cells
(mEpiSCs) and human embryonic stem cells (hESCs), represent
the postimplantation epiblast, the next successive stage of plu-
ripotency, which occurs immediately prior to differentiation into
the three germ cell lineages at gastrulation (Brons et al., 2007;
Najm et al., 2011; Tesar et al., 2007; Thomson et al., 1998). There
is tremendous interest in understanding the differences between
the naive and primed pluripotent states because they provide a
direct window into the epigenetic dynamics in placental mam-
mals that function to maintain pluripotency while simultaneously
preparing to transition to a somatic regulatory program.
Enhancer elements establish and maintain expression pat-
terns that drive normal development and cell identity. In compar-
ison to promoters, the chromatin state of enhancers is divergent
across different cell types. Even genes expressed broadly
across different cell types can show dramatic differences in
enhancer usage (Kieffer-Kwon et al., 2013). Recent evidence
suggests that large genomic domains containing clusters of
active enhancers, variously referred to as ‘‘super enhancers,’’
‘‘stretch enhancers,’’ or ‘‘multiple enhancer variants’’ are partic-
ularly cell type specific, and they are proposed to mediate tran-
scription of genes that are important for controlling cell identity
(Corradin et al., 2014; Hnisz et al., 2013; Love´n et al., 2013;
Parker et al., 2013; Whyte et al., 2013). These discoveries have
largely been garnered from comparisons of regulatory land-
scapes of cell types derived from very different tissues and
distinct stages of development. Here, we employ genomic ap-
proaches to directly characterize the regulatory landscapes of
two closely related cell types, mESCs and mEpiSCs. These
cell types represent successive snapshots of early development,
share the core property of pluripotency, and largely share a com-
mon transcriptional program; however, their maintenance relies
on distinct signaling pathways. Our analyses show that enhancer
usage differs not only for genes that are differentially expressed
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larly expressed between the two cell types. While enhancers
unique to mESCs are decommissioned following the transition
to primed pluripotency, those unique to mEpiSCs, which we
term seed enhancers, are present in naive pluripotency, become
active in primed pluripotency, and retain activity in somatic deriv-
atives, often contributing to super enhancers.
RESULTS
Enhancer Profiles Distinguish Mouse Pluripotent States
To understand the differences in transcriptional regulation
between mESCs and mEpiSCs, we performed epigenomic and
transcriptome profiling of these two pluripotent cell types using
high-quality ChIP-seq and RNA-seq data sets (see Table S1 and
FigureS1A available online).We focused our epigenomic analysis
on cis-regulatory regions known to be marked by specific
chromatin features:H3K4me1, associatedwithputative enhancer
elements (Heintzman et al., 2007, 2009; Wang et al., 2008);
H3K4me3, associatedwith transcriptionstart sites (TSSs) (Heintz-
man et al., 2007, 2009; Wang et al., 2008); H3K27ac, enriched at
active promoters and enhancers (Creyghton et al., 2010; Rada-
Iglesias et al., 2011; Wang et al., 2008; Zentner et al., 2011);
H3K27me3, generally associatedwith transcriptionally repressed
regions of chromatin (Rada-Iglesias et al., 2011; Schwartz and
Pirrotta, 2007; Zentner et al., 2011); and DNase-seq, indicative
of open regions of chromatin (Song et al., 2011).
Through analysis of the RNA-seq and ChIP-seq data, we
determined the number of transcripts differentially expressed
between mESCs and mEpiSCs, as well as the number of pro-
moters and enhancers that showed chromatin state differences
between the two cell types (Figure 1A). The transcriptomes of
mESCs and mEpiSCs were remarkably similar to one another
(R2 = 0.83; n = 4 biological replicates per cell type), with less
than 6% (852 out of 15,198) of expressed transcripts (fragments
per kilobase per million mapped reads [FPKM] > 0.25) showing
a significant difference in abundance between mESCs and
mEpiSCs. Among this list were transcripts of genes known to
be mESC specific, including Esrrb, Zfp42, Dppa3, and Klf4, as
well as those known to be mEpiSC specific, including Fgf5,
Cer1, and Lefty1 (Figure 1B; see also Figure 1D and Table S2).
Global promoter states were also largely similar, with over
73% of 10,560 active (H3K27ac+) promoters overlapping be-
tween the two cell types (Figures 1A and 1B). Even promoters
of differentially expressed genes (referred to as mESC-enriched
and mEpiSC-enriched) showed a similar state of DNase hyper-
sensitive open chromatin (Figures 1D–1F). In stark contrast,
chromatin states at the 22,156 H3K4me1+ H3K27ac+ enhancer
loci were much more distinctive, showing only 27% overlap (Fig-
ures 1A and 1C). These data suggest that the enhancer land-
scape may play a dominant role in defining differences between
pluripotent cell types on a molecular level.
We next used a computational approach called PreSTIGEouse
to assign enhancers to mESC-enriched and mEpiSC-enriched
genes (see Experimental Procedures). Enhancers of mESC-
enriched genes contained all signature features of active
elements in mESCs (H3K4me1, H3K27ac, and DNase hyper-
sensitivity) and were decommissioned in mEpiSCs (Figure 1E).
Globally, enhancers of mEpiSC-enriched genes are markedby an active enhancer signature in both cell types (Figure 1F).
Half of the enhancers of mEpiSC-enriched genes lack marks
of active enhancer elements in mESCs, while half are marked
by an active enhancer signature in both. These data suggest
that the enhancer landscape of mESCs is primed to activate
mEpiSC-enriched genes at the successive developmental stage.
However, fewer than 8% of enhancers that differ between
mESCs and mEpiSCs could be accounted for by differences at
mESC- and mEpiSC-enriched genes.
Pluripotency-Enriched Genes Show Dramatic Enhancer
Differences between Pluripotent States
To further explore the global enhancer differences between
mESCs and mEpiSCs, we asked whether genes expressed
at similar levels between mESCs and mEpiSCs, including
many pluripotency-related factors, are regulated by distinct en-
hancers. It is known that thePou5f1, also known asOct3/4, locus
is controlled by distinct enhancers in the preimplantation inner
cell mass versus the postimplantation epiblast in vivo as well
as in mESCs versus mEpiSCs in vitro (Tesar et al., 2007; Yeom
et al., 1996). However, it was not known whether this represents
a global regulatory phenomenon. To test this hypothesis, we first
defined a set of ‘‘pluripotency-enriched’’ genes using RNA-seq
data sets from mESC, mEpiSCs, and a panel of 18 develop-
mental and adult mouse cell and tissue types. We set stringent
metrics to ensure that genes within this class are expressed
at similar levels in mESCs and mEpiSCs (p > 0.05 and <2-fold
change between mESCs and mEpiSCs) and enriched in the
two pluripotent cell types in comparison to a panel of 18 different
mouse tissues (Figure 2A and Table S2). As expected, this
pluripotency-enriched gene class contained gene ontology
terms consistent with pluripotent phenotypes (Figure S1B) and
the genes share a nearly identical active chromatin state at their
promoters (Figure 2B). Consistent with their role in regulating key
cell identity genes, 25% of these pluripotency-enriched genes
were associated with super enhancers in either of the two
cell types (Figure S1C). However, the locations of these super
enhancers in the two cell types were largely nonoverlapping,
indicating a distinct control mechanism even for these similarly
expressed pluripotency-enriched genes.
Weassignedenhancer elements toeachpluripotency-enriched
gene using a computational approach called PreSTIGEouse
(see Experimental Procedures). Of the 602 pluripotency-enriched
genes, 97% showed evidence of differential enhancer usage
between the two pluripotent cell types. An example is shown in
Figure 2C. Here, the five enhancer elements predicted in mESCs
to regulate Kdm5b, an exemplar pluripotency-enriched gene, are
highlighted in blue (Figures 2C and 2D). All five enhancers are
located in open chromatin and contain high levels of H3K4me1
and H3K27ac (Figure 2C). In mEpiSCs these five enhancers
are virtually devoid of H3K4me1 and H3K27ac, and a different
enhancer (highlighted in red) is predicted to regulate Kdm5b.
We next selected all enhancers that, like those associated
with Kdm5b in mESCs, were predicted to regulate pluripo-
tency-enriched genes exclusively in mESCs. These enhancers,
which we call ‘‘naive-dominant,’’ generally contained high levels
of H3K4me1 and H3K27ac in mESCs relative to mEpiSCs,
where enhancer-histone signals were low or near background
levels (Figures 2E, 2F, and S2A). Thus, most naive-dominantCell Stem Cell 14, 854–863, June 5, 2014 ª2014 Elsevier Inc. 855
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Figure 1. Enhancer Profiles Distinguish Mouse Pluripotent States
(A) Venn diagrams showing the number and overlap of expressed transcripts (left), H3K27ac+ promoters of expressed genes (center), and H3K27ac+ enhancers
(right) detected in mESCs and mEpiSCs.
(B) Heatmap of expression differences between mESCs and mEpiSCs (log2 transformed, [average of mESC replicates]/[average of mEpiSC replicates]) ranked
from high to low (left). Known mESC- and mEpiSC-enriched genes are listed to the left. Windowed chromatin heatmaps comparing DNase HS, H3K4me3,
H3K27ac, and H3K27me3 profiles ± 5 kb of promoters in mESCs and mEpiSCs are ranked in the same order as expression data (right).
(C) Windowed heatmaps contrasting DNase HS, H3K4me1, H3K27ac, and H3K27me3 signal ± 5 kb from the midpoint of DNase-centered putative enhancers
identified in mESCs or mEpiSC. Enhancers are ranked from most to least mESC-specific (compared to mEpiSCs) based on H3K4me1 peak intensities.
(legend continued on next page)
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Pluripotent Stem Cell States Reveal Seed Enhancersenhancers are largely inactivated, or ‘‘lost’’ upon transition of
mESCs to the mEpiSC state. We next selected ‘‘primed-domi-
nant’’ enhancers, or those predicted to regulate the pluripo-
tency-enriched genes exclusively in mEpiSCs. As expected,
these enhancers contained high levels of the active enhancer
marks H3K4me1 and H3K27ac in mEpiSCs (Figures 2E, 2F,
and S2B). However, unexpectedly, these same enhancers
were enriched for H3K4me1 and H3K27ac in mESCs, albeit at
lower levels than in mEpiSCs (Figures 2E, 2F, and S2B). These
enhancers were not assigned to gene targets in mESCs due
to the relatively low levels of the associated enhancer histone
marks. As a result of their apparent switch from dormancy in
the naive state to active transcriptional regulation in the primed
state, we refer to these as ‘‘seed enhancers.’’ We compared
seed enhancers to a class of ‘‘shared enhancers,’’ i.e.,
enhancers predicted to regulate pluripotency-enriched genes
in both cell types. Despite their relatively low signal intensity
in mESCs, seed enhancers contain the highest levels of
H3K4me1 and H3K27ac among all mEpiSC enhancers of plurip-
otency-enriched genes (Figure S2C), suggesting the importance
of the seed enhancer in the active regulation of the pluripo-
tency-enriched genes.
To test whether the chromatin signal at seed enhancers in
mESCs could be an artifact caused by metastable heterogeneity
within mESC cultures, we tested if the seed enhancers were
present in mESCs grown under defined ‘‘2i’’ culture conditions,
which are thought to promote a more homogeneous population
of naive cells (Ying et al., 2008). We find that, similar to mESCs
grown in standard conditions, nearly all seed enhancer loci are
marked by H3K4me1 in mESCs grown in 2i conditions and that
half of these sites are also marked with H3K27ac, while the
other half aremarkedwithH3K27me3 (Figures 2E andS2B). Addi-
tionally, the levels of Pecam1 expression can distinguish
mESCs in culture that are more naive-like from cells that are
more epiblast-like (Furusawa et al., 2004; Hayashi et al., 2008).
We used FACS to separate mESCs into Pecam1-high and
Pecam1-low populations (Figure S2D), followed by immediate fix-
ation andChIP-seq. The seedenhancerswere found tobepresent
at nearly identical levels in both populations (Figure S2E), further
supporting the idea that the presence of seed enhancers in
mESCs is not the result of a contaminating epiblast-like popula-
tion. Using publically available chromatin interactionmaps gener-
ated through Hi-C experiments, we validated the fact that
compared to naive-dominant enhancers, seed enhancers rarely
physically interact with the promoters of pluripotency-enriched
genes in mESCs (Figure 2G). Additionally, compared to naive-
dominant enhancers, seed enhancers are infrequently occupied
by components of the mediator-cohesin complex (Med12, Nipbl,
and Smc1) in mESCs, which are known to physically link en-
hancerswith their targetpromoters (Figure2H) (Kageyetal., 2010).
Seed enhancers show increased sequence conservation and
are generally located farther from the TSSs of genes they control
than naive-dominant enhancers are (Figures S2F–S2H). Motif
analysis of the two classes revealed that many of the transcrip-(D) Row normalized expression of transcripts differentially expressed (also deno
(E) Aggregate plots depicting average ChIP-seq and DNase-seq signals at prom
(F) Same as (E), but for mEpiSC-enriched genes.
See also Figure S1, Table S1, and Table S2.tion factors enriched at seed enhancers overlap with those found
at naive-dominant enhancers (Table S3). It is interesting that
naive-dominant enhancers exclusively are enriched for both
known naive-specific factors, such as Esrrb and Tcfcp2l1,
and pluripotency factors, such as Oct4, Nanog, and Sox2. Addi-
tionally, naive-dominant enhancers are enriched for motifs of
Smad2/3 and Smad4, key downstream mediators of the Acti-
vin/Nodal pathway required for mEpiSC maintenance (Brons
et al., 2007; Nomura and Li, 1998; Tesar et al., 2007; Weinstein
et al., 1998). Collectively, these results suggest a mechanism
by which Activin/Nodal signaling may be required for repression
of naive-dominant enhancers during the transition to primed
pluripotency.
We asked if the control of pluripotency-enriched genes by
seed enhancers was a mouse specific molecular feature or if it
extended more broadly to other mammalian pluripotent cells
such as hESCs. Although embryo-derived hESCs exist in a
primed pluripotent state similar to mEpiSCs, recent work has
shown that hESCs can be converted into a naive-like state using
extrinsic factors (Chan et al., 2013; Gafni et al., 2013; Ware et al.,
2014). We took advantage of available enhancer-histone modifi-
cation ChIP-seq data from this model system to test if the dy-
namic enhancer changes observed in mESCs and mEpiSCs
are recapitulated in human pluripotent stem cells. To do this, a
set of human pluripotency-enriched genes were selected and
assigned to enhancers using methods similar to those used in
mouse. Similar to our observations in mouse cells, these human
cells contained robust naive-dominant enhancers that lack
chromatin markers of enhancer activity in the primed state, as
well as seed-like enhancers with more robust activity in the
primed state than the naive cell state (Figures S3A–S3I). These
data suggest that an early developmental transition from a naive
pluripotency-reinforcing epigenomic state to a primed somatic
differentiation-capable state may be a general phenomenon of
mammalian development.
Seed Enhancers Are Utilized in Downstream Tissues
Where They Expand into Enhancer Clusters
Collectively, our findings suggest that the global transcriptional
control of pluripotency genes is quite distinct between the naive
and primed phases of pluripotency. While genes have been
shown to be controlled by distinct enhancers in completely
different cell types (Kieffer-Kwon et al., 2013), we found it puz-
zling as to why genes expressed at virtually identical levels in
successive cell stages would undergo enhancer switching.
This question prompted us to investigate additional features
of seed enhancers. Given that seed enhancers show greater
sequence conservation than typical enhancers, we asked if
theymight play a role at later stages of development. Using avail-
able H3K27acChIP-seq data from 15 different mouse embryonic
and adult tissues, we found that 21% of seed enhancers were
significantly enriched for H3K27ac in at least one tissue (Figures
3A and 3B). The rate of seed enhancer usage in downstream
tissues was nearly double that of naive-dominant enhancers,ted as enriched) between mESCs and mEpiSCs, ranked as in (B).
oters and enhancers of mESC-enriched genes in mESCs and mEpiSCs.
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Pluripotent Stem Cell States Reveal Seed Enhancersshared enhancers, and a control set of mouse embryonic fibro-
blast enhancers (indicative of the background rate of enhancer
usage in multiple tissues) (Figure 3C). This trend held true across
all 15 tissues (Figure 3D).
Upon visual inspection of the seed enhancers in the down-
stream tissues, we noticed that several were contained within
large domains of chromatin broadly marked with H3K4me1.
For example, the Cct3 gene is a pluripotency-enriched gene
regulated by two seed enhancers in mEpiSCs (Figure 3E) that is
also expressed in embryonic brain (Figure 3F). Both seed
enhancers become components of a large enhancer domain in
embryonic brain. Domains like these are likely composed of mul-
tiple individual enhancer elements and are reminiscent of super
and stretch enhancers. To test the significance of these observa-
tions, we determined the number of seed enhancers that lie
within an enhancer cluster (defined as four or more enhancers
within 100 kb) in a downstream tissue (Figure 3G). Seed en-
hancers were more likely than naive-dominant enhancers to lie
within enhancer clusters in four different tissues: embryonic
brain, cortex, olfactory bulb, and embryonic heart (Figure 3G).
By comparison, naive-dominant enhancerswere not significantly
enriched in enhancer clusters of any downstream tissue tested.
Given the propensity for seed enhancers to lie within neural-
related enhancer clusters, we identified how often a seed
enhancer gives rise to an enhancer cluster in at least one of
the four neural tissues in our panel (embryonic brain, cortex,
olfactory bulb, and cerebellum) and found that 29% of all seed
enhancers fall within an enhancer cluster in one of these neural
tissues (Figure 3H). We found the same enrichment for seed en-
hancers in regions that become super enhancers in these four
neural tissues (Figure 3I). Interestingly, given the tendency for
seed enhancers to contribute to super enhancers or enhancer
clusters in neural tissues, seed enhancers that resolve in any
downstream tissue are enriched for motifs associated with neu-
ral lineage transcription factors, including Ascl2, Sox6, Olig2,
and Neurod1 (Figure 3J and Table S3).
DISCUSSION
Here we compared the transcriptomes and epigenomic land-
scapes of naive mESCs and primed mEpiSCs. We report twoFigure 2. Pluripotency-Enriched Genes Show Dramatic Enhancer Diffe
(A) Heatmap depicting row normalized expression of pluripotency-enriched gene
between mESCs and mEpiSCs, and are relatively specific to mESCs and mEpiS
(B) Aggregate plots of DNase hypersensitivity and histone marks at the promoters
(right).
(C) UCSC Browser image depicting the Kdm5b locus and the naive-dominant enh
the seed enhancers (highlighted in red) predicted to regulate its expression in mE
Gray boxes identify the Kdm5b promoter. The Rabif gene was not predicted to b
(D) Expression levels (mean ± SD) of pluripotency-enriched transcript Kdm5b (top
(E) Aggregate plots of enhancers associated with the pluripotency-enriched gen
otency-enriched genes in the mESC state, but not in the mEpiSC state. Seed enh
not in mESCs. mESCs grown in standard conditions and 2i conditions are show
(F) Boxplots depicting differences in the levels of enhancer histone marks betw
mapped reads) at naive-dominant enhancers (top) and seed enhancers (bottom)
(G) Percentage of pluripotency-enriched genes associated with naive-dominant
*p < 0.002).
(H) Percentage of pluripotency-enriched genes for which both the gene target
complex (Med12, Nipbl, and Smc1) (Fischer’s Exact Test, **p < 0.0001).
See also Figures S2 and S3.unexpected observations. First, pluripotency-enriched genes
shared between mESCs and mEpiSCs are regulated by distinct
enhancer elements in each cell type. Thus, the known differen-
tial enhancer regulation of the Oct3/4 locus between naive and
primed states may represent a well-studied example of a more
general mechanism of enhancer switching at other pluripotency
genes. Second, we show that enhancers actively regulating
pluripotency-enriched genes in mEpiSCs often exist as
dormant seed enhancers in mESCs. The seed enhancers are
not in physical contact with the promoters of the pluripo-
tency-enriched genes in mESCs, but they appear to take up
primary transcriptional control in the sequential mEpiSC state.
Seed enhancers appear to be epigenetically and functionally
distinct from previously described ‘‘poised’’ and ‘‘latent’’ en-
hancers. Poised enhancers are comarked with H3K4me1 and
H3K27me3 in mESCs, whereas many seed enhancers lack
H3K27me3 in mESCs (Rada-Iglesias et al., 2011; Zentner
et al., 2011). Additionally, poised enhancers are not active in
mESCs, nor do they regulate genes that are transcriptionally
active in pluripotent cells. In contrast to seed enhancers that
take over control of already expressed genes, poised
enhancers regulate genes that become active upon differ-
entiation. Latent enhancers altogether lack the signature
enhancer-histone marks and acquire them only upon response
to cell stimulation (Ostuni et al., 2013). By comparison, seed
enhancers are present but not engaged in mESCs, and they
persist through the mEpiSC state into more terminally differen-
tiated cell types.
This raises the questions of why seed enhancers exist and
what their precise function is. While further studies are clearly
required, one possibility is that seed enhancers function in
mESCs to ensure transcriptional robustness of the associated
target gene. This hypothesis has been proposed for shadow en-
hancers in Drosophila melanogaster (Hong et al., 2008; Perry
et al., 2010). However, if seed enhancers ensure proper gene
expression, we might expect them to be in physical contact
with their target gene promoters in mESCs, which was clearly
not the case. A more attractive hypothesis is that seed en-
hancers act as ‘‘placeholders’’ in the naivemESC state to ensure
that the proper enhancer is utilized in the primed pluripotent state
and in subsequent stages of development. It will be particularlyrences between Pluripotent States
s. These genes are not differentially expressed (p > 0.05), have <2-fold change
Cs compared to downstream tissues (see Experimental Procedures).
of pluripotency-enriched genes (depicted in A) in mESCs (left) and in mEpiSCs
ancers (highlighted in blue) predicted to regulate its expression in mESCs and
piSCs using the PreSTIGEouse methodology (see Experimental Procedures).
e regulated by these enhancers.
) and nonpluripotency-enriched transcriptRabif (bottom) in indicated cell types.
es. Naive-dominant enhancers are predicted to regulate expression of plurip-
ancers are predicted to regulate pluripotency-enriched genes in mEpiSCs, but
n.
een the two cell types as measured by RPKM (reads per kilobase per million
(paired sample Wilcoxon signed rank test, *p < 0.0001).
enhancers and seed enhancers in mESC Hi-C data sets (Fisher’s Exact Test,
and an associated enhancer are bound by subunits of the mediator-cohesin
Cell Stem Cell 14, 854–863, June 5, 2014 ª2014 Elsevier Inc. 859
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Cell Stem Cell
Pluripotent Stem Cell States Reveal Seed Enhancersinteresting to test whether seed enhancers are a phenomenon
specific to the unique preimplantation to postimplantation transi-
tion of placental mammals or are something more general within
developmental and stem cell hierarchies.
EXPERIMENTAL PROCEDURES
Cell Culture
Pluripotent stem cells were cultured as previously described (Chenoweth and
Tesar, 2010; Najm et al., 2011; Tesar et al., 2007). For details see Supplemental
Experimental Procedures.
Sequencing Experiments
ChIP and DNase sequencing experiments were performed as previously
described (Schmidt et al., 2009; Song et al., 2011). RNA sequencing libraries
were prepared using the Illumina TruSeq RNA Sample Preparation Kit accord-
ing to the manufacturer’s protocol. For details see Supplemental Experimental
Procedures.
Data Sets
Data sets used in this study are summarized in Table S1 (Buecker et al., 2014;
ENCODE Project Consortium, 2011; Gafni et al., 2013; Kagey et al., 2010;
Marks et al., 2012; Selvaraj et al., 2013; Shen et al., 2012; Wamstad et al.,
2012).
Predicting Gene Targets of Enhancers with PreSTIGEouse
The PreSTIGE (Predicting Specific Tissue Interactions of Genes and En-
hancers) bioinformatics algorithm was utilized to associate enhancer/gene
pairs (Corradin et al., 2014). PreSTIGE predicts enhancer-gene pairs based
on genomic proximity (<100 kb) and shared specificity of enhancer
H3K4me1 signal and gene expression as compared to a panel of 12 tissues.
PreSTIGE was initially developed to interrogate human enhancer-gene pairs
and was adapted for application to mouse (PreSTIGEouse). Predictions are
available at http://genetics.case.edu/prestige/. For details see Supplemental
Experimental Procedures.
ACCESSION NUMBERS
mEpiSC ChIP-seq, mEpiSC DNase-seq, and mESC and mEpiSC RNA-seq
data sets generated for this publication are available on the NCBI Gene
Expression Omnibus website in GEO Series GSE57409.Figure 3. Seed Enhancers Are Utilized in Downstream Tissues Where
(A) Pie chart depicting the fraction of seed enhancers that show a chromatin sta
(B) Heatmap displaying the downstream tissues in which each seed enhancer is
displays H3K27ac signal intensity above threshold in the given cell type.
(C) Percentage of seed enhancers (red) active in at least one downstream tissu
enhancers shared between mESCs and mEpiSCs (white) (Fisher’s Exact Test, *p <
background level of enhancer utilization.
(D) Percent of seed enhancers active in each downstream tissue (red) compare
common to mESCs and mEpiSCs (shared; white).
(E) Genome browser image depicting the Cct3 gene and the enhancers predicte
active promoters, while blue boxes identify naive-dominant enhancers. The red
enhancer in embryonic brain (black box), but not bone marrow.
(F) Expression (mean ± SD) of Cct3 (right) is high in pluripotent cells and embry
predicted to target neighboring gene Rhbg (left).
(G) Percent of enhancers located in a cluster of enhancers (defined as four or mo
Seed enhancers (red) are significantly more likely to occur in enhancer clusters th
and embryonic heart (Fisher’s Exact Test, *p < 0.003). The background rate for a
(H) Percentage of seed enhancers (red), naive-dominant enhancers (blue), and all e
G) in one of the four neural tissues in the panel (embryonic brain, cortex, olfacto
(I) As in (H), but for regions that are super enhancers in neural tissues.
(J) Motifs enriched among seed enhancers that are active in downstream tissues
See also Table S3.SUPPLEMENTAL INFORMATION
Supplemental Information for this article includes three figures, three tables,
and Supplemental Experimental Procedures and can be found with this article
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